| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | VP Research and Development | Aug 23, 2018 | Option Exercise | $1.82 | 13,736 | 25,000 | 61,267 | Aug 27, 2018, 09:33 PM | |
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | VP Research and Development | Apr 30, 2018 | Option Exercise | $3.27 | 2,743 | 8,970 | 29,593 | May 02, 2018, 07:23 AM | |
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | VP Research and Development | Mar 15, 2018 | Buy | $3.96 | 5,000 | 19,777 | 26,850 | Mar 19, 2018, 05:27 PM | |
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | VP Research and Development | Feb 02, 2018 | Option Exercise | $1.52 | 13,926 | 21,211 | 21,850 | Feb 05, 2018, 07:14 PM | |
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | VP Research and Development | Oct 31, 2017 | Option Exercise | $7.17 | 1,743 | 12,497 | 7,924 | Nov 02, 2017, 02:24 PM | |
| OBLN | OBALON THERAPEUTICS INC | Drake Neil | Director | Apr 30, 2017 | Option Exercise | $9.03 | 1,661 | 14,999 | 6,181 | May 02, 2017, 06:52 PM |
Menu